ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 82 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,388,000 | -63.0% | 54,000 | -62.5% | 0.79% | +24.6% |
| Q2 2021 | $3,756,000 | -42.5% | 144,000 | -22.2% | 0.63% | -47.9% |
| Q1 2021 | $6,536,000 | +24.0% | 185,142 | -11.3% | 1.21% | +96.4% |
| Q4 2020 | $5,270,000 | -23.6% | 208,798 | +14.1% | 0.62% | -48.4% |
| Q3 2020 | $6,901,000 | -31.4% | 183,000 | -22.2% | 1.20% | -54.5% |
| Q2 2020 | $10,067,000 | +1539.6% | 235,098 | +643.8% | 2.63% | +1711.0% |
| Q1 2020 | $614,000 | -32.1% | 31,608 | -9.2% | 0.14% | -30.0% |
| Q4 2019 | $904,000 | -69.1% | 34,811 | -67.6% | 0.21% | -62.2% |
| Q3 2019 | $2,928,000 | -59.0% | 107,441 | -59.6% | 0.55% | -38.4% |
| Q2 2019 | $7,149,000 | -49.6% | 266,269 | -45.7% | 0.89% | -56.6% |
| Q1 2019 | $14,179,000 | -18.9% | 490,438 | -24.5% | 2.05% | -43.7% |
| Q4 2018 | $17,494,000 | – | 649,607 | – | 3.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |